Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

for
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 2 - 70

Code: NCT03938987

Phase1, Phase2, Recruiting

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Edmonton, Saskatoon, Spokane WA, Vancouver, Seattle WA,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase3, Recruiting

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

for
Relapsing Remitting Multiple Sclerosis (RRMS)
Location: Edmonton, Calgary, Burnaby, Vancouver, Ottawa, Quebec,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06733922

Recruiting

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

for
Leber Congenital Amaurosis 10, Blindness,
Location: Edmonton, Minneapolis MN, San Francisco CA,
Sponsor: Laboratoires Thea

Sex: All

Age: 6+

Code: NCT06891443

Phase3, Recruiting

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

for
Glioma
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT00813787

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

for
Immune-related Adverse Event, Diarrhea, Advanced Melanoma,
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05663775

Phase2, Recruiting

A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients

for
Breast Neoplasms
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: Female

Age: 18+

Code: NCT01740271

Phase2, Recruiting